Heart risk in patients hospitalized for COPD flare-ups
Part of Lungs & breathing clinical trials.
This study follows people who are in the hospital for a COPD flare-up to see how their heart and blood vessels are affected. You might join if you're 40 or older and have confirmed COPD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- You are in the hospital because your COPD flared up and got much worse.
- A doctor has confirmed your COPD with a breathing test.
- You are not pregnant.
- You are not currently getting chemotherapy or comfort-focused (palliative) care for cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a coordinated (multidisciplinary) care program for people with severe COPD who were recently hospitalized for worsening breathing symptoms. It may help reduce future flare-ups and improve day-to-day breathing by coordinating multiple types of care in a COPD center.
This study tests a software program that uses machine learning to predict if you might have a COPD flare-up or get worse within 60 days after leaving the hospital. The goal is to help doctors provide better follow-up care and reduce emergency visits.
This trial tests whether a supervised exercise and breathing program while in the hospital helps older patients recover from a sudden COPD flare-up. It aims to improve your strength and breathing so you can get back to normal activities more quickly.
This trial looks at how the heart and lungs work together during a severe COPD flare-up that requires hospital care. It may help doctors find better ways to treat breathing problems in the ICU.
This study looks at how a COPD flare-up might affect the heart in people who haven't had a heart attack or known heart muscle damage before. It uses a simple heart ultrasound to check for stress-related changes.
This trial studies cardiovascular (heart and blood vessel) risk in people who have stable COPD or a recent worsening of COPD. It may help researchers understand which risks to monitor during and after a COPD flare and how to prevent complications.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.